TMCnet News

Global Healthcare/Medical Simulation Market 2017-2022 by Product, Service, and End User - A $2.57 Billion Opportunity - ResearchAndMarkets.com
[January 19, 2018]

Global Healthcare/Medical Simulation Market 2017-2022 by Product, Service, and End User - A $2.57 Billion Opportunity - ResearchAndMarkets.com


The "Healthcare/Medical Simulation Market by Product & Services, End User - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

The global Healthcare/Medical Simulation Market is projected to reach USD 2,575.4 Million by 2022 from USD 1,284.0 Million in 2017, at a CAGR of 14.9%.

The benefits of simulation over traditional learning, increasing demand for minimally invasive treatments, and increasing focus on patient safety are the major factors driving the growth of the medical simulations market.

In 2016, North America accounted for the largest share of the medical simulations market, followed by Europe and Asia Pacific. The ease of accessibility to technologies, well-established distribution channels, and rising number of healthcare professionals demanding hands on patient training are the major factors driving the growth of the medical simulations market in North America.

The shortage of healthcare personnel, technological advancements, and growing awareness for simulation education in emerging countries are expected to provide further growth opportunities for players operating in the medical simulation market. However, budgetary constraints, high cost f simulators, and operational challenges are some of the factors limiting the growth of this market during the forecast period.



Laerdal Medical (Norway) held the leading position in the global healthcare/medical simulation market in 2016. Over the past three years, the company has been focusing on expanding its product portfolio in various simulation subsegments by launching innovative products in order to lure customers and gain more market share. This is evident from its recent product launches of Nursing Anne Simulator and Little Anne QCPR. The company maintains strong partnerships with leading healthcare research institutes such as American Heart Association (US), American Academy of Pediatrics (US), British Heart Foundation (UK), National League for Nursing (US), and Stavanger Acute Medicine Foundation for Education & Research (Norway) on large-scale projects pertaining to innovative simulation technology development. Innovative products and the company's brand value helps the company maintain its leading position in the market.

Market Dynamics


Drivers

- Benefits of Simulation Over Traditional Learning

- Increasing Demand for Minimally Invasive Treatments

- Increasing Focus on Patient Safety

Restraints

- Budgetary Constraints

Opportunities

- Shortage of Healthcare Personnel

- Technological Advancements

- Growing Awareness on Simulation Education in Emerging Countries

Challenges

- High Cost of Simulators

- Operational Challenges

- Modelling and Simulation of Individual Tissues

- Difficulty in Achieving Multimodal Simulation

Companies Mentioned

- 3D Systems

- CAE

- Gaumard Scientific Company

- Kyoto Kagaku

- Laerdal Medical

- Limbs & Things

- Medaphor

- Mentice

- Simulab

- Simulaids

For more information about this report visit https://www.researchandmarkets.com/research/558fpm/global?w=4


[ Back To TMCnet.com's Homepage ]